Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,399 public trials 1,305 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy

NCT01287585

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Southern California Research Center Coronado, California, United States
  • Catherine Frenette La Jolla, California, United States
  • Stanford University Palo Alto, California, United States
View all 73 locations
View Trial Details
Completed

Monitoring the IMmUological TOXicity of Drugs

NCT03480529

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France
  • Rhumatology department, CHU Strasbourg, Hautepierre hospital Strasbourg, France
View Trial Details
Completed

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

NCT03516071

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Nanfang Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
View all 15 locations
View Trial Details
Completed

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

NCT03212521

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Parkway Medical Center /ID# 161261 Birmingham, Alabama, United States
  • Arkansas Gastroenterology /ID# 161266 North Little Rock, Arkansas, United States
  • UC Davis Medical Center /ID# 161138 Sacramento, California, United States
  • Yale University /ID# 161258 New Haven, Connecticut, United States
View all 42 locations
View Trial Details
Completed

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

NCT01837381

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Department of Clinicl Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong
  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinsese University of Hong Kong Hong Kong
  • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong
View Trial Details

Related conditions